Authors: DUBOIS A VACH W CRAMERGIRAUD U THOMSSEN C GLAUBITZ M FIOLA M AUGENER W BARTSCH W BERGMANN F BIERBAUM W KRAPP J BONING L BONGARTZ U BRUNTSCH U VONBULTZINGSLOWEN F DIETL J FUGER T FULLE HH GATZEMEIER U GROPP C HARTLAPP H HERSCHLEIN HJ HOLTKAMP W HURST U JANICKE F KAUKEL E KLEEBERG U ENGEL E KRAFFT W KUHNLE H LINDEMANN H MARSCHNER N MEERPOHL HG NIEDERLE N OSIEKA R PLANKER M RIESS H SCHMIDT M SCHMOLL HJ SCHUNEMANN H WEINGARTJESSE B WEITZEL H WESTERHAUSEN M WINKELMANN M

Citation: A. Dubois et al., PATTERN OF CARBOPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6(5), 1995, pp. 645-651

Authors: MARSCHNER N KREIENBERG R BALAS R BRANDTNER M SCHLINGENSIEPEN R SCHUMANN S BUTTNER S STAAB HJ RAUSCHNING W

Citation: N. Marschner et al., DROLOXIFENE IN POSTMENOPAUSAL PATIENTS WI TH METASTATIC BREAST-CANCER- DOUBLE-BLIND RANDOMIZED PHASE-II STUDY, Onkologie, 17, 1994, pp. 32-39

Authors: KAUFMANNKOLLE P DREVS J BERGER MR KOTTING J MARSCHNER N UNGER C EIBL H

Citation: P. Kaufmannkolle et al., PHARMACOKINETIC BEHAVIOR AND ANTINEOPLASTIC ACTIVITY OF LIPOSOMAL HEXADECYLPHOSPHOCHOLINE, Cancer chemotherapy and pharmacology, 34(5), 1994, pp. 393-398

Authors: MARSCHNER N KREIENBERG R SOUCHON R RATH U EGGELING B VOIGTMANN R RUFFERT K SCHUTTE M AMMON A KESZTYUS T KAPLAN E NAGEL G

Citation: N. Marschner et al., EVALUATION OF THE IMPORTANCE AND RELEVANCE OF DOSE INTENSITY USING EPIRUBICIN AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER - INTERIM ANALYSIS OF A PROSPECTIVE RANDOMIZED TRIAL, Seminars in oncology, 21(1), 1994, pp. 10-16

Authors: MARSCHNER N

Citation: N. Marschner, ONDANSETRON IN THE TREATMENT OF NAUSEA AND VOMITING - INTRODUCTION, Anti-cancer drugs, 4, 1993, pp. 3-7

Authors: BREITBACH GP MARSCHNER N

Citation: Gp. Breitbach et N. Marschner, DROLOXIFEN IN METASTATIC BREAST-CANCER - DOSAGE AND PHARMACOKINETICS, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 903-905